MedTrace Logo

Evaluation of Nutrition and Metabolism in Breast Cancer Patients

NCT01542216 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-11-05

No results posted yet for this study

Summary

With the increased success in breast cancer therapies, survivors develop unhealthy changes in body composition, such as muscle loss and fat gains, which lead to increased risk of cardiovascular disease and diabetes in survivorship. This study will examine the effects of a nutrition, cardiovascular and strength exercise program compared with a yoga program (representing usual care) on body composition and metabolism in recently diagnosed breast cancer patients. Nutrition and exercise may improve various body composition and metabolic parameters, which may improve quality of life in survivorship, reduce risk of recurrence and reduce the risk of developing cardiovascular disease and diabetes in survivorship.

Conditions

Interventions

BEHAVIORAL

Nutrition and Exercise Group

Patients randomized to this arm will receive nutrition and exercise consultations. Exercise consultations will home- and institution-based.

BEHAVIORAL

Yoga and Stretching Group

Patients randomized to this arm will receive consultations on yoga and stretching exercises.

Sponsors & Collaborators

  • Grand River Regional Cancer Centre

    collaborator OTHER

  • University of Waterloo

    lead OTHER

Principal Investigators

  • Marina Mourtzakis, PhD · University of Waterloo

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-06-30
Completion
2015-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542216 on ClinicalTrials.gov